Centro de Imagem Diagnósticos S.A. (AALR3.SA)
BRL 9.95
(-1.49%)
BRL 9.95
(-1.49%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.17 Billion BRL | 8.72% |
| 2022 | 1.08 Billion BRL | -4.54% |
| 2021 | 1.13 Billion BRL | 22.37% |
| 2020 | 928.78 Million BRL | -13.43% |
| 2019 | 1.07 Billion BRL | -0.38% |
| 2018 | 1.07 Billion BRL | -0.09% |
| 2017 | 1.07 Billion BRL | 13.29% |
| 2016 | 951.47 Million BRL | 35.99% |
| 2015 | 699.66 Million BRL | 77.96% |
| 2014 | 393.14 Million BRL | 42.5% |
| 2013 | 275.89 Million BRL | 49.79% |
| 2012 | 184.18 Million BRL | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 317.73 Million BRL | 13.19% |
| 2024 Q1 | 280.7 Million BRL | -2.6% |
| 2023 FY | 1.17 Billion BRL | 8.72% |
| 2023 Q1 | 289.65 Million BRL | 10.31% |
| 2023 Q2 | 299.41 Million BRL | 3.37% |
| 2023 Q3 | 302.33 Million BRL | 0.97% |
| 2023 Q4 | 288.18 Million BRL | -4.68% |
| 2022 FY | 1.08 Billion BRL | -4.54% |
| 2022 Q4 | 262.58 Million BRL | -6.47% |
| 2022 Q3 | 280.75 Million BRL | 5.34% |
| 2022 Q1 | 275.15 Million BRL | 2.02% |
| 2022 Q2 | 266.51 Million BRL | -3.14% |
| 2021 FY | 1.13 Billion BRL | 22.37% |
| 2021 Q1 | 285.18 Million BRL | -2.64% |
| 2021 Q4 | 269.7 Million BRL | -9.64% |
| 2021 Q2 | 283.21 Million BRL | -0.69% |
| 2021 Q3 | 298.47 Million BRL | 5.39% |
| 2020 Q1 | 235.86 Million BRL | -10.03% |
| 2020 FY | 928.78 Million BRL | -13.43% |
| 2020 Q4 | 292.91 Million BRL | 12.91% |
| 2020 Q3 | 259.43 Million BRL | 84.55% |
| 2020 Q2 | 140.57 Million BRL | -40.4% |
| 2019 Q4 | 262.15 Million BRL | -5.07% |
| 2019 Q2 | 272.71 Million BRL | 4.15% |
| 2019 FY | 1.07 Billion BRL | -0.38% |
| 2019 Q1 | 261.84 Million BRL | 1.2% |
| 2019 Q3 | 276.14 Million BRL | 1.26% |
| 2018 Q4 | 258.75 Million BRL | -7.41% |
| 2018 FY | 1.07 Billion BRL | -0.09% |
| 2018 Q1 | 263.14 Million BRL | 2.98% |
| 2018 Q2 | 275.56 Million BRL | 4.72% |
| 2018 Q3 | 279.46 Million BRL | 1.41% |
| 2017 Q3 | 292.67 Million BRL | 8.24% |
| 2017 Q1 | 259.27 Million BRL | 0.12% |
| 2017 FY | 1.07 Billion BRL | 13.29% |
| 2017 Q4 | 255.52 Million BRL | -12.69% |
| 2017 Q2 | 270.4 Million BRL | 4.29% |
| 2016 Q1 | 195.72 Million BRL | 7.63% |
| 2016 Q2 | 243.03 Million BRL | 24.17% |
| 2016 FY | 951.47 Million BRL | 35.99% |
| 2016 Q4 | 258.97 Million BRL | 2.07% |
| 2016 Q3 | 253.73 Million BRL | 4.4% |
| 2015 Q3 | 185.02 Million BRL | 8.21% |
| 2015 Q1 | 161.79 Million BRL | 0.0% |
| 2015 FY | 699.66 Million BRL | 77.96% |
| 2015 Q4 | 181.85 Million BRL | -1.72% |
| 2015 Q2 | 170.98 Million BRL | 5.68% |
| 2014 FY | 393.14 Million BRL | 42.5% |
| 2013 FY | 275.89 Million BRL | 49.79% |
| 2012 FY | 184.18 Million BRL | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Diagnósticos da América S.A. | 14.25 Billion BRL | 91.724% |
| Fleury S.A. | 6.47 Billion BRL | 81.771% |